Literature DB >> 19801105

Study of robustness of IMPT and IMRT for prostate cancer against organ movement.

Martin Soukup1, Matthias Söhn, Di Yan, Jian Liang, Markus Alber.   

Abstract

PURPOSE: Intensity-modulated radiotherapy with photons (IMRT) and protons (IMPT) produces dose distributions that have high conformality to the planning target volume and sufficient sparing of the organs at risk if calculated on a single static computed tomography (CT) scan. For prostate cancer patients, organ movement with related changes to the density distribution in the irradiated volume occurs during the treatment course. We evaluated the sensitivity of IMPT and IMRT plans to organ movement. METHODS AND MATERIALS: IMPT and IMRT treatment plans were evaluated for 4 patients with an average of 16 CT data sets per patient. The treatment plans were recalculated on all treatment CT scans, and the dose was accumulated in the reference geometry using a deformable registration algorithm. Accurate dose calculation methods were applied for both IMPT and IMRT.
RESULTS: With IMPT, unacceptably low total doses in the gross tumor volume were observed for patients with gas in the rectum on the planning CT scan. To achieve a total equivalent uniform dose (EUD) and EUD spread similar to that with IMRT, two methods were crucial for IMPT-a rectal gas water-equivalent density overwrite in the original planning CT scan and initial beam weight setting to achieve a homogeneous dose distribution for the whole planning target volume for each field separately. An improvement in the total EUD for the prostate and rectal wall was also observed for IMRT with the water-equivalent density overwrite of the rectal cavities.
CONCLUSION: The sensitivities of IMPT and IMRT to organ movement are of the same order if appropriate planning strategies are applied. The latter is especially crucial for IMPT.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19801105     DOI: 10.1016/j.ijrobp.2009.04.032

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  20 in total

Review 1.  Technological advances in radiation therapy for prostate cancer.

Authors:  Mehee Choi; Arthur Y Hung
Journal:  Curr Urol Rep       Date:  2010-05       Impact factor: 3.092

2.  Initial development of goCMC: a GPU-oriented fast cross-platform Monte Carlo engine for carbon ion therapy.

Authors:  Nan Qin; Marco Pinto; Zhen Tian; Georgios Dedes; Arnold Pompos; Steve B Jiang; Katia Parodi; Xun Jia
Journal:  Phys Med Biol       Date:  2017-01-31       Impact factor: 3.609

3.  A Prospective Comparison of the Effects of Interfractional Variations on Proton Therapy and Intensity Modulated Radiation Therapy for Prostate Cancer.

Authors:  Maryam Moteabbed; Alexei Trofimov; Gregory C Sharp; Yi Wang; Anthony L Zietman; Jason A Efstathiou; Hsiao-Ming Lu
Journal:  Int J Radiat Oncol Biol Phys       Date:  2015-12-29       Impact factor: 7.038

4.  Comparison of different adjuvant radiotherapy approaches in childhood bladder/prostate rhabdomyosarcoma treated with conservative surgery.

Authors:  Frank Heinzelmann; Daniela Thorwarth; Ulf Lamprecht; Theodor W Kaulich; Jörg Fuchs; Guido Seitz; Martin Ebinger; Rupert Handgretinger; Michael Bamberg; Martin Weinmann
Journal:  Strahlenther Onkol       Date:  2011-10-29       Impact factor: 3.621

5.  Comparison of MCNPX and Geant4 proton energy deposition predictions for clinical use.

Authors:  U Titt; B Bednarz; H Paganetti
Journal:  Phys Med Biol       Date:  2012-09-21       Impact factor: 3.609

6.  Performance validation of deformable image registration in the pelvic region.

Authors:  V Zambrano; H Furtado; D Fabri; C Lütgendorf-Caucig; J Góra; M Stock; R Mayer; W Birkfellner; D Georg
Journal:  J Radiat Res       Date:  2013-07       Impact factor: 2.724

7.  Multifield optimization intensity-modulated proton therapy (MFO-IMPT) for prostate cancer: Robustness analysis through simulation of rotational and translational alignment errors.

Authors:  Thomas J Pugh; Richard A Amos; Sandra John Baptiste; Seungtaek Choi; Quyhn Nhu Nguyen; X Ronald Zhu; Matthew B Palmer; Andrew K Lee
Journal:  Med Dosim       Date:  2013-06-06       Impact factor: 1.482

Review 8.  Clinical controversies: proton therapy for prostate cancer.

Authors:  Kent W Mouw; Alexei Trofimov; Anthony L Zietman; Jason A Efstathiou
Journal:  Semin Radiat Oncol       Date:  2013-04       Impact factor: 5.934

9.  Equivalence of Gyn GEC-ESTRO guidelines for image guided cervical brachytherapy with EUD-based dose prescription.

Authors:  William Shaw; William I D Rae; Markus L Alber
Journal:  Radiat Oncol       Date:  2013-11-13       Impact factor: 3.481

10.  Passive proton therapy vs. IMRT planning study with focal boost for prostate cancer.

Authors:  Inhwan Yeo; Prashanth Nookala; Ian Gordon; Reinhard Schulte; Stanley Barnes; Abiel Ghebremedhin; Ning Wang; Gary Yang; Ted Ling; David Bush; Jerry Slater; Baldev Patyal
Journal:  Radiat Oncol       Date:  2015-10-24       Impact factor: 4.309

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.